F8 and hemophilia: Similarly, an Austrian haemophilia registry study reported median (IQR) ABRs of 4.9 (1.6, 13.5) for all bleeding events and 4.1 (0.9, 12.3) for joint bleeding in 26 participants with severe HA receiving FVIII prophylaxis; the median (Q1, Q3) annualised FVIII utilisation was 3364 (2219, 4297) IU/kg/yr [20].